y 27632 has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 640 | 13 | 233 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sims, SM; Yaghi, A | 1 |
1 other study(ies) available for y 27632 and 20-hydroxy-5,8,11,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Calcium; Calcium Signaling; Cell Nucleus; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hydroxyeicosatetraenoic Acids; Lung Diseases; Male; Muscle Contraction; Muscle, Smooth; NFATC Transcription Factors; Organ Culture Techniques; Phenylephrine; Protein Isoforms; Pulmonary Artery; Pyridines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2005 |